صفحه اصلی   فرم ثبت نام   تماس با ما     English
Scientific Programبرنامه کنگره

 

DETAILED PROGRAMME

 

 

DAY 1 – SATURDAY, 28 OCTOBER 2017

 

 

 

 

 

 

 

 

 

 

 

 

 

SPEAKER

PROGRAMME

TIME

 

The Recitation of the Holy Quran , National Anthem of the Islamic Republic of Iran

7:30 – 8:00

Ardeshir Ghavamzadeh&Kamran Alimoghaddam

Welcome & Opening Remarks

8:00-8:30

Chairpersons: Ardeshir Ghavamzadeh &  Shinichiro Okomato

Plenary 1: APBMT/WBMT Joint Session: Transplantation  reports in asian pacific region & Progress of BMT in world and asian pacific region

8:30-10:00

Ardeshir Ghavamzadeh,Mani Ramzi & Mahshid Mehdizadeh

The report of transplantation in all BMT centers of Iran in five recent years(Tehran,Tabriz,Ahvaz, Sari,Kermanshah, Shiraz,Kerman, Babol, Mashhad,Urmia)

8:30-8:50

Shinichiro Okamoto

The report of transplantation in Japan  in five recent years and Infrastructure of Long term follow up system in Japan

8:50-9:00

Yoshihisa Kodera

The history, current status and future trends of WBMT

9:00-9:10

Huang He

The report of transplantation in china  in five recent years

9:10-9:20

Yoshihisa Kodera

Advance of HSCT after the enforcement of "The Act for Appropriate Provision of Hematopoietic Stem Cells to be Used in Transplantations" in Japan

9:20-9:30

 Lalindra Gooneratne

The report of transplantation in Sri Lanka  in five recent years

9:30-9:40

Mohiuddin Ahmed Khan

The report of transplantation in  Bangeladesh  in five recent years

9:40-9:50

Aye Aye Gyi

The report of transplantation in  Myanmar  in five recent years

9:50-10:00

 

 

 

 

Tea Break

10:00-10:30

Chairpersons: Huang He, Richard K. Burt

Plenary 2:Educational session of Immunotherapy in Transplantation Era: CART Cell

10:30-13:00

Kevin Hay

Toxicity of CAT therapy

10:30-10:50

Antonia Muller

New and old Targets for CART-Cell

10:50-11:10

Richard K. Burt

Advanced CD19-CART Therapy for acute lymphocytic leukemia and B cell Lymphoma/USA perspective

11:10-11:30

Kevin Hay

clinical experience with CD19 CAR for lymphoid malignancies

11:30-11:50

Huang He

Advanced CD19-CART therapy for acute lymphocytic leukemia and B cell Lymphoma/China Perspective

11:50-12:10

Huang He,Kevin Hay,Richard K. Burt,Antonia Muller

Panel Discussion

12:10-12:30

 

 

 

 

Pray& Lunch

12:30-14:00

 

 

 

Chairpersons: Mary Horowitz, Ardeshir Ghavamzadeh

Plenary 3: Haploidentical and other related transplantation/MRD in post transplantation Era

14:00-16:00

Huang He

Haploidentical hematological stem cell transplantation as front line therapy for adult Acute Lymphocytic Leukemia

14:00-14:20

Mary Horowitz

HCT in 2017: Everyone Has A Donor

14:20-14:40

Richard K. Burt

Haploidentical Hematological stem cell transplantation as front line therapy for adult Acute Lymphocytic Leukemia

14:40-15:00

Mohammad Vaezi

Haploidentical Hematological stem cell transplantation reports of Hematology,Oncology and SCT Reserch Center of Iran

15:00-15:20

Koichi Miyamura

MRD in Philadephila Positive ALL patients post-transplant

15:20-15:40

 Mary Horowitz,Huang He,Richard K. Burt,Mohammad Vaezi,Koichi Miyamura

Panel Discussion

15:40-16:00

 

Tea Break

16:00-16:30

 

Poster Presentation

16:00-17:30

 

DAY2-SUNDAY, 29 OCTOBER 2017

 

SPEAKER

PROGRAMME

TIME

Chairpersons: Amir Ali Hamidieh,Amir Abbas Hedayati Asl

Plenary 4:Transplantation in Pediatrics

8:30-10:00

Amir Ali Hamidieh

 

8:30-8:50

Amir Abbas Hedayati Asl

Transplantation outcome  in  Pediatiric Philadelphia positive ALL patients

8:50-9:10

Tahereh Rostami

Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute B-Cell Lymphoblastic Leukemia Carrying High Risk Chromosomal Translocations: A Retrospective Single Center Study

9:10-9:25

Blank

Blank

9:25-9:45

Amir Ali Hamidieh,Amir Abbas Hedayati Asl,Tahereh Rostami

Panel Discussion

9:45-10:00

 

 

 

 

Tea Break

10:00-10:30

Chairpersons: Mary Horowitz, Reiner Storb

Plenary 3: Transplantation in older and non malignant patients/MRD in Transplantation Era

10:30-13:00

Rainer Storb

Transplantation in older patients

10:30-10:50

Mary Horowitz

HCT for Myelodysplastic Syndromes

10:50-11:10

Rainer Storb

Transplantation for patients with non-malignant blood disorders

11:10-11:30

Koichi Miyamura

Persistent challenge of detection of minimal residual disease

11:30-11:50

Mehrdad Payandeh

Transplant in patients with comorbid disease

11:50-12:10

Mary Horowitz,Rainer Storb,Mehrdad Payandeh,Koichi Miyamura,

Panel Discussion

12:10-12:30

 

 

 

 

Pray& Lunch

12:30-14:00

Chairpersons:Robert Negrin,Abbas Hajfathali

Plenary 4: Pre and Post transplantation treatment:{Allogeneic, Autologous, NK cell,DLI}

14:00-16:00

Hans Jochem Kolb

Prophylactic and pre-emptive DLI

14:00-14:20

Mazyar Shadman

Transplant for double or triple hit lymphoma and their management

14:20-14:40

Robert Negrin

Novel strategies for allogeneic transplantation and tolerance induction

14:40-15:00

Mazyar Shadman

Post transplant maintenance in lymphoid malignancies

15:00-15:20

Blank

Blank

15:20-15:40

Mazyar Shadman, Hans Jochem Kolb,Robert Negrin,Abbas Hajfathali

Panel Discussion

15:40-16:00

 

Tea Break

16:00-16:30

 

Poster Presentation

16:00-17:30

 

 

 

 

DAY3-MONDAY 30 OCTOBER 2017

 

SPEAKER

PROGRAMME

TIME

Chairpersons: Robert Negrin, Kamran Alimoghadam,Rainer Storb

Plenary 5: Educational Session of Cell therapy and regenerative medicine, GVHD and transplantation in non malignant diseases

8:30-10:00

Rainer Storb

graft-versus-host disease and graft-versus-tumor effects

8:30-8:45

Antonia Muller

Chronic GVHD and immune function post allo-HSCT

8:45-9:00

Nicolas Kröger

Treatment options for steroid refractory GvHD

9:00-9:15

Robert Negrin

Role of regulatory T cells in GVHD prevention and treatment

9:15-9:30

Nicolas Kröger

Role of ATG in preventing GvHD after allogeneic SCT

9:30-9:45

Robert Negrin,Koichi Miyamura,Kamran Alimoghadam,Antonia Muller

Panel Discussion

9:30-10:00

 

 

 

 

Tea Break

10:00-10:30

Chairpersons: Seyed Asadollah Mousavi,Mohamad Vaezi, Hossein Kamranzadeh

Oral Presentations from submitted abstracts

10:30-13:00

Koichi Miyamura

Insurance approval of mesenchymal stem cell therapy for steroid refractory acute GVHD in Japan

10:30-10:50

Blank

Blank

10:50-11:10

Blank

Blank

11:10-11:30

Blank

Blank

11:30-11:50

Blank

Blank

11:50-12:10

 

Panel Discussion

12:10-12:30

 


سخنرانان مدعو
پیام رئیس کنگره

We are delighted to welcome you to the congress of the APBMT inTehran, Iran, 2017.

It is our great pleasure to invite you to participate in the next APBMT conference which will be held in Tehran, Iran next year. The APBMT conference is a great opportunity to bring together scholars from the Asia pacific region to communicate and exchange ideas in order to improve the outcome of HSCT.We are honored to have invited well-known and esteemed scientists whose work, research and efforts need no introduction.Now I would like to draw your attention to a brief overview over beauties of Iran and events organized successfully by Iranian society of stem cell transplant. Our research institute actively involved in arranging important national and international conferences in hematology oncology and stem cell transplantation such as APBMT conference which was held in Tehran in 2004 and APCC conference in 2007. We are looking forward to meeting you in Tehran

Prof. Ardeshir Ghavamzadeh
President of the Congress

 

ورود اعضا
نام کاربری :
کلمه عبور :
 
  کلمه عبور خود را فراموش کرده ام.
فرم ثبت نام در کنگره راهنمای ارسال خلاصه مقاله لیست کارگاه های کنگره معرفی کنگره
درباره ایران
اخبار
عضویت در خبرنامه
حامیان کنگره
لطفا ایمیل خود را جهت دریافت خبرنامه وارد کنید
آمار بازديدها
تماس با ما
روز شمار
امروز 64
ماه جاری 5405
کل مراجعات 6995
نشانی: تهران،خيابان جلال آل احمد،بيمارستان شريعتي،مركز تحقيقات هماتولوژي،انكولوژي و پيوند سلولهاي بنيادي،انجمن پيوند سلولهاي بنيادي خونساز ايران
تلفن: 02184902668 2184902662 02184902635
فکس: 02188004140
رایانامه: horcbmt@sina.tums.ac.ir